This post was originally published on this site
Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates, mostly in Africa, Southeast Asia …
Headline
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it? – AP News
Back To Top